AstraZeneca CEO Pascal Soriot, who has been critical of the U.K.’s business environment for the life sciences industry, is directing a big chunk of money into the Big Pharma’s home country.
AZ plans to invest £650 million ($827 million) in the U.K., Chancellor Jeremy Hunt announced Wednesday.
